DK1043332T3 - Dipeptider indeholdende cyclopentan-beta-aminosyrer - Google Patents

Dipeptider indeholdende cyclopentan-beta-aminosyrer

Info

Publication number
DK1043332T3
DK1043332T3 DK00110958T DK00110958T DK1043332T3 DK 1043332 T3 DK1043332 T3 DK 1043332T3 DK 00110958 T DK00110958 T DK 00110958T DK 00110958 T DK00110958 T DK 00110958T DK 1043332 T3 DK1043332 T3 DK 1043332T3
Authority
DK
Denmark
Prior art keywords
amino acids
beta amino
dipeptides containing
containing cyclopentane
cyclopentane
Prior art date
Application number
DK00110958T
Other languages
Danish (da)
English (en)
Inventor
Michael Matzke
Joachim Mittendorf
Hans-Christian Militzer
Franz Kunisch
Axel Schmidt
Wolfgang Schoenfeld
Karl Ziegelbauer
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of DK1043332T3 publication Critical patent/DK1043332T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrrole Compounds (AREA)
DK00110958T 1995-07-19 1996-07-08 Dipeptider indeholdende cyclopentan-beta-aminosyrer DK1043332T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19526274A DE19526274A1 (de) 1995-07-19 1995-07-19 Verbesserung der Verträglichkeit von pharmazeutisch wirksamen beta-Aminosäuren

Publications (1)

Publication Number Publication Date
DK1043332T3 true DK1043332T3 (da) 2007-03-12

Family

ID=7767189

Family Applications (2)

Application Number Title Priority Date Filing Date
DK96110967T DK0754678T3 (da) 1995-07-19 1996-07-08 Forbedring af tolerencen af farmaceutisk aktive beta-aminosyrer
DK00110958T DK1043332T3 (da) 1995-07-19 1996-07-08 Dipeptider indeholdende cyclopentan-beta-aminosyrer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK96110967T DK0754678T3 (da) 1995-07-19 1996-07-08 Forbedring af tolerencen af farmaceutisk aktive beta-aminosyrer

Country Status (45)

Country Link
US (1) US5935988A (fr)
EP (2) EP0754678B1 (fr)
JP (2) JP3891503B2 (fr)
KR (1) KR100433968B1 (fr)
CN (1) CN1115145C (fr)
AR (1) AR003465A1 (fr)
AT (2) ATE344274T1 (fr)
AU (1) AU713555B2 (fr)
BG (1) BG62134B1 (fr)
BR (1) BR9603124A (fr)
CA (1) CA2181308A1 (fr)
CO (1) CO4700525A1 (fr)
CU (1) CU22820A3 (fr)
CZ (2) CZ287896B6 (fr)
DE (3) DE19526274A1 (fr)
DK (2) DK0754678T3 (fr)
DZ (1) DZ2073A1 (fr)
EE (1) EE03803B1 (fr)
ES (2) ES2154761T3 (fr)
GR (1) GR3035601T3 (fr)
HK (1) HK1005131A1 (fr)
HR (1) HRP960303B1 (fr)
HU (1) HUP9601977A3 (fr)
IL (1) IL118869A (fr)
MA (1) MA23940A1 (fr)
MX (1) MX9602836A (fr)
NO (1) NO315926B1 (fr)
NZ (1) NZ299008A (fr)
PE (1) PE9398A1 (fr)
PL (1) PL184861B1 (fr)
PT (2) PT1043332E (fr)
RO (1) RO118656B1 (fr)
RS (1) RS49520B (fr)
RU (1) RU2181123C2 (fr)
SA (1) SA96170491B1 (fr)
SG (1) SG47158A1 (fr)
SI (2) SI1043332T1 (fr)
SK (2) SK284733B6 (fr)
SV (1) SV1996000062A (fr)
TN (1) TNSN96100A1 (fr)
TR (1) TR199600583A2 (fr)
TW (1) TW496737B (fr)
UA (1) UA46725C2 (fr)
YU (1) YU20050685A (fr)
ZA (1) ZA966111B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191306B1 (en) * 1999-08-03 2001-02-20 Eastman Chemical Company Process for the preparation of cyclopropylglycine
KR20010073441A (ko) * 2000-01-14 2001-08-01 최인도 패류종묘 착상판의 제조방법
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US20060014697A1 (en) 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
US7700561B2 (en) * 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
US7659253B2 (en) 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
US7105486B2 (en) * 2002-02-22 2006-09-12 New River Pharmaceuticals Inc. Abuse-resistant amphetamine compounds
AU2004251647B2 (en) * 2003-05-29 2010-01-14 Takeda Pharmaceutical Company Limited Abuse resistant amphetamine compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716278D0 (en) * 1987-07-10 1987-08-19 Fujisawa Pharmaceutical Co Antimicrobial agent
JPH02174753A (ja) * 1988-08-25 1990-07-06 Fujisawa Pharmaceut Co Ltd シス―２―アミノシクロペンタンカルボン酸誘導体およびその製法ならびに抗菌剤
US5631291A (en) * 1992-05-29 1997-05-20 Bayer Aktiengesellschaft Cyclopentane- and -pentene-β-amino acids
DE4302155A1 (de) * 1993-01-27 1994-07-28 Bayer Ag Verwendung von Cyclopentan- und -penten-beta-Aminosäuren
AU673824B2 (en) * 1992-05-29 1996-11-28 Bayer Aktiengesellschaft Cyclopentane- and -pentene-beta-amino acids
GB9216441D0 (en) * 1992-08-03 1992-09-16 Ici Plc Fungicidal process
WO1995007022A1 (fr) * 1993-09-07 1995-03-16 Zeneca Limited Fongicides
DE19548825C2 (de) * 1995-12-27 1999-03-25 Rolf Dr Hermann Neue, substituierte Cyclopentylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19604225A1 (de) * 1996-02-06 1997-08-07 Bayer Ag Stoffzusammensetzungen aus alpha-Aminosäuren und Cyclohexen-beta-aminosäuren

Also Published As

Publication number Publication date
AU713555B2 (en) 1999-12-02
HK1005131A1 (en) 1998-12-24
RO118656B1 (ro) 2003-08-29
PL315330A1 (en) 1997-01-20
KR970006312A (ko) 1997-02-19
GR3035601T3 (en) 2001-06-29
PT754678E (pt) 2001-04-30
SG47158A1 (en) 1998-03-20
CZ214396A3 (en) 1997-02-12
DE59606266D1 (de) 2001-02-08
DK0754678T3 (da) 2001-02-05
JP3891503B2 (ja) 2007-03-14
MX9602836A (es) 1997-01-31
CZ288204B6 (en) 2001-05-16
PL184861B1 (pl) 2003-01-31
SK94796A3 (en) 1997-02-05
AU5948896A (en) 1997-01-23
HRP960303B1 (en) 2001-08-31
SI0754678T1 (en) 2001-04-30
CU22820A3 (es) 2003-01-29
CZ287896B6 (cs) 2001-03-14
ES2275460T3 (es) 2007-06-16
EE9600109A (et) 1997-02-17
ATE344274T1 (de) 2006-11-15
SK281850B6 (sk) 2001-08-06
JP2007056026A (ja) 2007-03-08
US5935988A (en) 1999-08-10
KR100433968B1 (ko) 2004-08-30
EP1043332A1 (fr) 2000-10-11
RU2181123C2 (ru) 2002-04-10
TR199600583A2 (tr) 1997-02-21
CA2181308A1 (fr) 1997-01-20
AR003465A1 (es) 1998-08-05
EP0754678A2 (fr) 1997-01-22
BR9603124A (pt) 1998-04-22
SI1043332T1 (sl) 2007-04-30
HU9601977D0 (en) 1996-09-30
NO963000L (no) 1997-01-20
CN1115145C (zh) 2003-07-23
DZ2073A1 (fr) 2002-07-22
NO315926B1 (no) 2003-11-17
EP0754678A3 (fr) 1997-12-17
HUP9601977A3 (en) 1998-04-28
NO963000D0 (no) 1996-07-18
PT1043332E (pt) 2007-01-31
RS49520B (sr) 2006-10-27
MA23940A1 (fr) 1997-04-01
HUP9601977A2 (en) 1997-05-28
CN1143496A (zh) 1997-02-26
YU20050685A (sh) 2006-08-17
IL118869A0 (en) 1996-10-31
YU41796A (sh) 1999-06-15
DE19526274A1 (de) 1997-01-23
PE9398A1 (es) 1998-04-15
SV1996000062A (es) 1997-06-26
CO4700525A1 (es) 1998-12-29
SA96170491B1 (ar) 2006-09-20
TNSN96100A1 (fr) 2005-03-15
NZ299008A (en) 1998-05-27
BG62134B1 (bg) 1999-03-31
ATE198469T1 (de) 2001-01-15
EP0754678B1 (fr) 2001-01-03
EP1043332B1 (fr) 2006-11-02
IL118869A (en) 2002-03-10
DE59611398D1 (de) 2006-12-14
TW496737B (en) 2002-08-01
ES2154761T3 (es) 2001-04-16
EE03803B1 (et) 2002-08-15
ZA966111B (en) 1997-02-03
UA46725C2 (uk) 2002-06-17
HRP960303A2 (en) 1998-02-28
BG100716A (bg) 1997-04-30
JPH09202761A (ja) 1997-08-05
SK284733B6 (sk) 2005-10-06

Similar Documents

Publication Publication Date Title
FI953837A (fi) Synteettisiä aktivoituvia aminohappoja
DK0845003T3 (da) Hidtil ukendte opioid-peptider
NO993901D0 (no) Bisykliske aminosyrer
NO964304L (no) Sötningsstoffsalter
LV10962A (lv) Jauni peptidi
NO950477D0 (no) Aminosyrederivater
BR9610239A (pt) Proteínas de fusão-alérgeno-xcd32
DE69635886D1 (de) Exzitatorisch wirkende Aminosäurederivate
FI970168A (fi) Peptidejä
BR9609671A (pt) Amino uracilas substituídas
DK1043332T3 (da) Dipeptider indeholdende cyclopentan-beta-aminosyrer
DE69427363D1 (de) Plättchenaggregationsinhibierende peptide
BR9606756A (pt) Peptídeo
NO981052D0 (no) Peptidderivater
NO981051D0 (no) Peptidderivater
ATE471944T1 (de) Antineoplastische peptide
ATA114093A (de) Markierte alpha aminosäuren
SE9504467D0 (sv) Peptide
BR1100812A (pt) Peptìdeo
SE9502503D0 (sv) New amino acid derivatives
SE9502505D0 (sv) New amino acid derivatives
SE9502487D0 (sv) New amino acid derivatives
SE9503923D0 (sv) New amino acid derivatives
SE9504349D0 (sv) New amino acid derivatives
SE9502504D0 (sv) New amino acid derivatives